HomeGSK • BCBA
add
Glaxosmithkline CEDEAR
Previous close
$22,150.00
Day range
$21,760.00 - $22,250.00
Year range
$10,000.00 - $22,760.00
Market cap
124.14B USD
Avg Volume
21.00
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 8.62B | 6.17% |
Operating expense | 4.57B | -0.28% |
Net income | 636.00M | 53.62% |
Net profit margin | 7.38 | 44.71% |
Earnings per share | — | — |
EBITDA | 2.50B | 35.38% |
Effective tax rate | 23.47% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.41B | -21.27% |
Total assets | 61.12B | 2.78% |
Total liabilities | 45.16B | -2.62% |
Total equity | 15.96B | — |
Shares outstanding | 4.01B | — |
Price to book | 5.43K | — |
Return on assets | 5.87% | — |
Return on capital | 10.70% | — |
Cash Flow
Net change in cash
| (GBP) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 636.00M | 53.62% |
Cash from operations | 2.28B | -2.19% |
Cash from investing | -933.00M | 16.62% |
Cash from financing | -856.00M | -1.66% |
Net change in cash | 448.00M | 19.47% |
Free cash flow | 1.15B | -49.69% |
About
Founded
Dec 27, 2000
Website
Employees
68,629
